• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Why CohBar Shares Are Trading Lower By 161%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session

    5/23/23 1:46:33 PM ET
    $ABCL
    $ACHV
    $ANGN
    $AUVI
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Biotechnology: In Vitro & In Vivo Diagnostic Substances
    Health Care
    Get the next $ABCL alert in real time by email

    Gainers

    • CohBar, Inc. (NASDAQ:CWBR) shares jumped 161% to $4.05 after the company and Morphogenesis announced they have entered into a definitive agreement for an all-stock transaction forming a company combining expertise and resources to advance a late-stage oncology pipeline.
    • HeartCore Enterprises, Inc. (NASDAQ:HTCR) gained 76.6% to $2.26 following better-than-expected first-quarter results.
    • Ocean Biomedical, Inc. (NASDAQ:OCEA) shares climbed 63% to $8.57 after the company announced a patent award for novel cancer immunotherapy treatment, granted for prostate cancer, colon cancer, ovarian cancer, kidney cancer, breast cancer, glioblastoma, melanoma and lung cancer.
    • Shuttle Pharmaceuticals Holdings, Inc. (NASDAQ:SHPH) surged 44% to $1.50 after it was granted U.S. patent #11654157: Methods and compositions for cancer therapies that include delivery of halogenated thymidines and thymidine phosphorylase inhibitors in combination with radiation.
    • Unique Fabricating, Inc. (NYSE:UFAB) climbed 32.8% to $0.2599 after the company announced an accommodation agreement and new forbearance agreement to support a restructuring or sale.
    • Icosavax, Inc. (NASDAQ:ICVX) gained 29.7% to $10.21 after the company announced topline interim Phase 1 results for its bivalent VLP vaccine candidate IVX-A12 against RSV and hMPV in older adults.
    • mCloud Technologies Corp. (NASDAQ:MCLD) jumped 27% to $0.4567 after the company announced it has formed a special committee for the purpose of exploring strategic alternatives.
    • Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) gained 22.6% to $9.96.
    • IMAC Holdings, Inc. (NASDAQ:BACK) climbed 21.9% to $0.1702. Theralink signed definitive merger agreement to be acquired by IMAC Holdings.
    • TuSimple Holdings Inc. (NASDAQ:TSP) climbed 21.2% to $2.01.
    • Lexaria Bioscience Corp. (NASDAQ:LEXX) climbed 20.4% to $0.83. Lexaria Bioscience recently announced it completed its HOR-A22-1 study that showed significant enhancement in the oral delivery of the estrogen hormone estradiol.
    • PacWest Bancorp (NASDAQ:PACW) shares gained 20% to $8.23. PacWest Bancorp shares jumped around 20% on Monday after the company announced it entered into a loan purchase and sale agreement with a subsidiary of Kennedy-Wilson Holdings to sell a portfolio of 74 real estate construction loans. DA Davidson maintained PacWest Banc with a Neutral and raised the price target from $3 to $8.
    • Lifecore Biomedical, Inc. (NASDAQ:LFCR) shares gained 18% to $6.32 after the company announced it entered into $150 million in new financing, repaid its outstanding term loans and signed a new supply agreement to expact its HA fermentation capacity with Alcon.
    • Quanterix Corporation (NASDAQ:QTRX) gained 17.5% to $22.59. Goldman Sachs upgraded Quanterix from Neutral to Buy and raised the price target from $13 to $27.
    • Applied UV, Inc. (NASDAQ:AUVI) shares climbed 15.6% to $0.5512 after posting better-than-expected quarterly sales.
    • Angion Biomedica Corp. (NASDAQ:ANGN) gained 15.1% to $0.9159.
    • SeqLL Inc. (NASDAQ:SQL) shares surged 15% to $0.46 after gaining over 19% on Monday. SeqLL recently posted a wider first-quarter loss.
    • Navigator Holdings Ltd. (NYSE:NVGS) rose 14.2% to $15.00 following strong quarterly sales.
    • Myriad Genetics, Inc. (NASDAQ:MYGN) gained 12.9% to $22.67. Goldman Sachs upgraded Myriad Genetics from Sell to Buy and raised the price target from $18 to $25.
    • Sarcos Technology and Robotics Corporation (NASDAQ:STRC) surged 11.7% to $0.3857.
    • Wallbox N.V. (NYSE:WBX) surged 11.2% to $3.9583.
    • Terns Pharmaceuticals, Inc. (NASDAQ:TERN) jumped 11.2% to $12.55.
    • AbCellera Biologics Inc. (NASDAQ:ABCL) gained 11% to $7.34.
    • Movella Holdings Inc. (NASDAQ:MVLA) rose 9.9% to $2.11 after jumping around 18% on Monday.
    • CureVac N.V. (NASDAQ:CVAC) surged 9.5% to $10.59.
    • Yelp Inc. (NYSE:YELP) gained 9.2% to $35.51. Activist investor TCS Capital Management has built a stake in Yelp and urged the service-recommendation site to explore strategic alternatives, including a sale, the Wall Street Journal reported.
    • Cumberland Pharmaceuticals Inc. (NASDAQ:CPIX) shares rose 5.8% to $1.84. The FDA recently approved expanded labeling for Cumberland Pharmaceuticals’ Caldolor, an intravenously delivered formulation of ibuprofen, to now include use in infants.

    Losers

    • Netcapital Inc. (NASDAQ:NCPL) shares fell 32.8% to $1.62 after the company reported a registered direct offering of 1.1 million shares at $1.55 per share.
    • T2 Biosystems, Inc. (NASDAQ:TTOO) dropped 29% to $0.2001 after the company posted downbeat quarterly results and announced exploration of strategic alternatives and implementation of a restructuring program, including 30% incremental reduction of workforce completed this past week.
    • Kaspien Holdings Inc. (NASDAQ:KSPN) fell 27.6% to $0.4427. Kaspien Holdings reported voluntary delisting from the Nasdaq Capital Market effective on or about June 12.
    • Evolve Transition Infrastructure LP (NYSE:SNMP) dipped 26.6% to $0.0901 after the company announced a 1-for-30 reverse split.
    • Microvast Holdings, Inc. (NASDAQ:MVST) fell 22.3% to $1.71 after the US Energy Department reportedly cancelled contract negotiations for a $200 million award for the company.
    • Microbot Medical Inc. (NASDAQ:MBOT) fell 22.1% to $2.4850. Microbot Medical announced a $1.44 million registered direct offering of 655,569 shares of common stock at a price of $2.20 per share priced at the market under Nasdaq rules.
    • NantHealth, Inc. (NASDAQ:NH) fell 20.6% to $2.04.
    • Oncorus, Inc. (NASDAQ:ONCR) dropped 20% to $0.2480 after the company reported Q1 financial results.
    • Meihua International Medical Technologies Co., Ltd. (NASDAQ:MHUA) dropped 20% to $2.96.
    • D-Wave Quantum Inc. (NYSE:QBTS) fell 16.7% to $0.8501 after surging 110% on Monday.
    • Tenon Medical, Inc. (NASDAQ:TNON) declined 16.1% to $1.36. Tenon Medical recently posted downbeat quarterly results.
    • NexImmune, Inc. (NASDAQ:NEXI) dropped 15.2% to $0.4018.
    • Achieve Life Sciences, Inc. (NASDAQ:ACHV) declined 14.7% to $6.95 as the company reported topline results from Phase 3 ORCA-3 trial of cytisinicline.
    • Integra LifeSciences Holdings Corporation (NASDAQ:IART) fell 13.5% to $43.87 after the company announced it initiated a voluntary global recall of all products manufactured in its Boston facility distributed between March 1, 2018 and May 22, 2023.
    • Voyager Therapeutics, Inc. (NASDAQ:VYGR) fell 10.6% to $12.37.
    • Kingsoft Cloud Holdings Limited (NASDAQ:KC) dropped 10% to $4.2750 following weak quarterly results.
    • Biocept, Inc (NASDAQ:BIOC) shares dropped 9.6% to $4.4491 dipping over 25% on Monday. Biocept recently announced a 1-for-30 reverse stock split.
    • ToughBuilt Industries, Inc. (NASDAQ:TBLT) fell 9.1% to $0.9277 after reporting results for its first quarter.
    • Peraso Inc. (NASDAQ:PRSO) fell 8.3% to $0.3650 after gaining over 53% on Monday.
    • Zoom Video Communications, Inc. (NASDAQ:ZM) dropped 7% to $66.42. Zoom Video reported better-than-expected results for its first quarter and raised its full-year sales outlook.
    • BJ's Wholesale Club Holdings, Inc. (NYSE:BJ) dropped 6.4% to $65.18 following weak quarterly sales.

     

    Now Read This: Dow Drops Over 100 Points; Lowe's Earnings Top Views

    Get the next $ABCL alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ABCL
    $ACHV
    $ANGN
    $AUVI

    CompanyDatePrice TargetRatingAnalyst
    Achieve Life Sciences Inc.
    $ACHV
    4/21/2026$13.00Buy
    Canaccord Genuity
    D-Wave Quantum Inc.
    $QBTS
    4/20/2026$22.00Market Perform
    Northland Capital
    Integra LifeSciences Holdings Corporation
    $IART
    4/15/2026Buy → Hold
    Argus
    Terns Pharmaceuticals Inc.
    $TERN
    3/25/2026Buy → Neutral
    H.C. Wainwright
    Lifecore Biomedical Inc.
    $LFCR
    3/17/2026$5.50Mkt Perform → Outperform
    Barrington Research
    D-Wave Quantum Inc.
    $QBTS
    2/12/2026Buy
    TD Cowen
    Kingsoft Cloud Holdings Limited
    $KC
    2/11/2026$15.60Neutral → Buy
    Goldman
    Microbot Medical Inc.
    $MBOT
    2/10/2026$5.00Buy
    B. Riley Securities
    More analyst ratings

    $ABCL
    $ACHV
    $ANGN
    $AUVI
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Quanterix To Report First Quarter 2026 Financial Results on May 6, 2026

    Quanterix Corporation (NASDAQ:QTRX), a company transforming healthcare by accelerating biomarker breakthroughs from discovery to diagnostics, today announced that it will host a conference call on Wednesday, May 6, 2026, at 4:30 p.m. E.T., to discuss its first quarter 2026 financial results. Quanterix will issue a press release regarding its first quarter 2026 financial results prior to the conference call on Wednesday, May 6, 2026, after the market closes. The press release will be posted on the Quanterix website at http://www.quanterix.com/. In conjunction with this announcement, the Company will host a conference call on May 6, 2026, at 4:30 PM ET. The dial-in number for USA & Canada

    4/24/26 8:33:00 AM ET
    $QTRX
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    Spruce Point Capital Management Announces Investment Opinion: Releases Report and Strong Buy Research Opinion on Zoom Communications (NASDAQ: ZM)

    NOTE TO EDITORS: The Following Is an Investment Opinion Issued by Spruce Point Capital Management Provides Evidence the Bear Thesis on Zoom Shares Does Not Hold Up to Scrutiny Believes Zoom's Transformation Into a Comprehensive, Value-Added, AI-First Platform Poised to Drive Deeper Enterprise Penetration is Underappreciated Demonstrates Zoom is Trading at a Massive Discount to Its Intrinsic Value, Particularly Considering Its Share Ownership in AI Leader Anthropic Identifies A Range of Cost Structure, Organizational Effectiveness, Capital Allocation Practices, and Corporate Governance Concerns For Zoom to Address Announces It Has Sent the Zoom Board of Directors a Letter Containin

    4/24/26 8:30:00 AM ET
    $ZM
    Computer Software: Programming Data Processing
    Technology

    Merck Announces Expiration of Hart-Scott-Rodino Act Waiting Period to Acquire Terns Pharmaceuticals, Inc.

    Merck (NYSE:MRK), known as MSD outside of the United States and Canada, today announced that the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended ("HSR"), in connection with Merck's pending acquisition of Terns Pharmaceuticals, Inc. ("Terns") (NASDAQ:TERN) expired at 11:59 p.m., Eastern Time, on April 23, 2026. As previously announced on April 7, 2026, Merck commenced, through a subsidiary, a cash tender offer to purchase all outstanding shares of common stock of Terns, for $53.00 net in cash for each share of Terns common stock validly tendered and not validly withdrawn in the offer, without interest and less any applicable tax withholding. The ex

    4/24/26 6:45:00 AM ET
    $MRK
    $TERN
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ABCL
    $ACHV
    $ANGN
    $AUVI
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    New insider Tpg Gp A, Llc claimed ownership of 6,877,580 shares (SEC Form 3)

    3 - ACHIEVE LIFE SCIENCES, INC. (0000949858) (Issuer)

    4/24/26 5:03:09 PM ET
    $ACHV
    Biotechnology: In Vitro & In Vivo Diagnostic Substances
    Health Care

    New insider Iancovici Lucian claimed no ownership of stock in the company (SEC Form 3)

    3 - ACHIEVE LIFE SCIENCES, INC. (0000949858) (Issuer)

    4/24/26 5:01:21 PM ET
    $ACHV
    Biotechnology: In Vitro & In Vivo Diagnostic Substances
    Health Care

    Director Patten Jarrod M exercised 2,000 shares at a strike of $18.65 and sold $356,312 worth of shares (2,000 units at $178.16) (SEC Form 4)

    4 - Strategy Inc (0001050446) (Issuer)

    4/24/26 4:38:13 PM ET
    $STRC
    Wholesale Distributors
    Industrials

    $ABCL
    $ACHV
    $ANGN
    $AUVI
    SEC Filings

    View All

    Cumberland Pharmaceuticals Inc. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders

    8-K - CUMBERLAND PHARMACEUTICALS INC (0001087294) (Filer)

    4/24/26 5:08:24 PM ET
    $CPIX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Amendment: SEC Form SCHEDULE 13G/A filed by Recursion Pharmaceuticals Inc.

    SCHEDULE 13G/A - RECURSION PHARMACEUTICALS, INC. (0001601830) (Subject)

    4/24/26 4:11:56 PM ET
    $RXRX
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    SEC Form DEF 14A filed by Lifecore Biomedical Inc.

    DEF 14A - LIFECORE BIOMEDICAL, INC. \DE\ (0001005286) (Filer)

    4/24/26 4:09:37 PM ET
    $LFCR
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ABCL
    $ACHV
    $ANGN
    $AUVI
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    President and CEO Raha Samraat S. bought $199,844 worth of shares (40,000 units at $5.00), increasing direct ownership by 9% to 493,104 units (SEC Form 4)

    4 - MYRIAD GENETICS INC (0000899923) (Issuer)

    3/9/26 7:03:13 PM ET
    $MYGN
    Biotechnology: In Vitro & In Vivo Diagnostic Substances
    Health Care

    Large owner Thermopylae Holdings Ltd. bought $130,720 worth of shares (38,000 units at $3.44), increasing direct ownership by 0.07% to 56,134,097 units (SEC Form 4)

    4 - AbCellera Biologics Inc. (0001703057) (Issuer)

    3/2/26 2:16:40 PM ET
    $ABCL
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Director Phanstiel S. Louise bought $494,722 worth of shares (104,507 units at $4.73), increasing direct ownership by 59% to 281,951 units (SEC Form 4)

    4 - MYRIAD GENETICS INC (0000899923) (Issuer)

    2/27/26 4:46:18 PM ET
    $MYGN
    Biotechnology: In Vitro & In Vivo Diagnostic Substances
    Health Care

    $ABCL
    $ACHV
    $ANGN
    $AUVI
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Canaccord Genuity initiated coverage on Achieve Life Sciences with a new price target

    Canaccord Genuity initiated coverage of Achieve Life Sciences with a rating of Buy and set a new price target of $13.00

    4/21/26 7:30:27 AM ET
    $ACHV
    Biotechnology: In Vitro & In Vivo Diagnostic Substances
    Health Care

    Northland Capital initiated coverage on D-Wave Quantum with a new price target

    Northland Capital initiated coverage of D-Wave Quantum with a rating of Market Perform and set a new price target of $22.00

    4/20/26 8:26:05 AM ET
    $QBTS
    EDP Services
    Technology

    Integra downgraded by Argus

    Argus downgraded Integra from Buy to Hold

    4/15/26 8:07:00 AM ET
    $IART
    Medical/Dental Instruments
    Health Care

    $ABCL
    $ACHV
    $ANGN
    $AUVI
    Leadership Updates

    Live Leadership Updates

    View All

    Yelp Launches the New Yelp Assistant, Transforming Local Discovery from Search to Answers and Actions

    The new AI-powered Yelp Assistant works across every category on Yelp and helps consumers book, order and schedule in one conversation New integrations with Vagaro, Zocdoc and Calendly expand seamless booking across Yelp Enhanced Menu Vision overlays dish photos on menus using a phone camera Yelp Inc. (NYSE:YELP), the company that connects people with great local businesses, announced its Spring Product Release, introducing more than 35 new features and updates that transform how consumers discover, connect and get things done with local businesses. The release unveils the new Yelp Assistant, an AI-powered chatbot that delivers instant answers, reliable recommendations and seamless bo

    4/21/26 7:00:00 AM ET
    $YELP
    Other Consumer Services
    Consumer Discretionary

    Netcapital Appoints Todd Violette as Chief Executive Officer

    BOSTON, MA, April 16, 2026 (GLOBE NEWSWIRE) -- Netcapital Inc. (NASDAQ:NCPL, NCPLW)) (the "Company"), a publicly traded fintech company that gives companies access to capital markets infrastructure without institutional-scale fees, today announced that its Board of Directors has appointed Mr. Violette to lead the Company in order to accelerate capital formation, expand platform reach, and build long-term shareholder value. Mr. Violette brings over 25 years of leadership experience across capital markets, fintech and digital asset-related businesses. His recent operating and executive roles have included CEO of CloudCover International, CEO of AppYea Inc., CEO of Vinergy, Chief Investment

    4/16/26 4:05:00 PM ET
    $NCPL
    Finance: Consumer Services
    Finance

    Achieve Life Sciences Announces Appointment of Andrew D. Goldberg, MD, as Chief Executive Officer and to the Board of Directors

    Achieve Names Two New Exemplary Healthcare Leaders to its Board of Directors  New Leadership and Financing, up to $354 Million ($180 Million Upfront and $174 Million Dependent on the Exercise of Milestone Warrants), Strengthen Achieve's Position to Execute Development and Launch of Cytisinicline, if Approved, as the First New Treatment for Nicotine Dependence in Two Decades SEATTLE and VANCOUVER, British Columbia, April 16, 2026 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc. (NASDAQ:ACHV) today announced it has appointed Andrew D. Goldberg, MD, as Chief Executive Officer and as a member of the Board of Directors, effective following the closing of Achieve's recently announced financing

    4/16/26 8:57:06 AM ET
    $ACHV
    Biotechnology: In Vitro & In Vivo Diagnostic Substances
    Health Care

    $ABCL
    $ACHV
    $ANGN
    $AUVI
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by Microvast Holdings Inc.

    SC 13D/A - Microvast Holdings, Inc. (0001760689) (Subject)

    11/21/24 9:41:30 PM ET
    $MVST
    Industrial Machinery/Components
    Miscellaneous

    Amendment: SEC Form SC 13G/A filed by Terns Pharmaceuticals Inc.

    SC 13G/A - Terns Pharmaceuticals, Inc. (0001831363) (Subject)

    11/15/24 10:35:07 AM ET
    $TERN
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Amendment: SEC Form SC 13G/A filed by D-Wave Quantum Inc.

    SC 13G/A - D-Wave Quantum Inc. (0001907982) (Subject)

    11/15/24 7:37:26 AM ET
    $QBTS
    EDP Services
    Technology

    $ABCL
    $ACHV
    $ANGN
    $AUVI
    Financials

    Live finance-specific insights

    View All

    Quanterix To Report First Quarter 2026 Financial Results on May 6, 2026

    Quanterix Corporation (NASDAQ:QTRX), a company transforming healthcare by accelerating biomarker breakthroughs from discovery to diagnostics, today announced that it will host a conference call on Wednesday, May 6, 2026, at 4:30 p.m. E.T., to discuss its first quarter 2026 financial results. Quanterix will issue a press release regarding its first quarter 2026 financial results prior to the conference call on Wednesday, May 6, 2026, after the market closes. The press release will be posted on the Quanterix website at http://www.quanterix.com/. In conjunction with this announcement, the Company will host a conference call on May 6, 2026, at 4:30 PM ET. The dial-in number for USA & Canada

    4/24/26 8:33:00 AM ET
    $QTRX
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    Spruce Point Capital Management Announces Investment Opinion: Releases Report and Strong Buy Research Opinion on Zoom Communications (NASDAQ: ZM)

    NOTE TO EDITORS: The Following Is an Investment Opinion Issued by Spruce Point Capital Management Provides Evidence the Bear Thesis on Zoom Shares Does Not Hold Up to Scrutiny Believes Zoom's Transformation Into a Comprehensive, Value-Added, AI-First Platform Poised to Drive Deeper Enterprise Penetration is Underappreciated Demonstrates Zoom is Trading at a Massive Discount to Its Intrinsic Value, Particularly Considering Its Share Ownership in AI Leader Anthropic Identifies A Range of Cost Structure, Organizational Effectiveness, Capital Allocation Practices, and Corporate Governance Concerns For Zoom to Address Announces It Has Sent the Zoom Board of Directors a Letter Containin

    4/24/26 8:30:00 AM ET
    $ZM
    Computer Software: Programming Data Processing
    Technology

    Yelp Announces Date of First Quarter 2026 Financial Results

    Yelp Inc. (NYSE:YELP), the company that connects people with great local businesses, announced that it will release its financial results for the quarter ended March 31, 2026 after the market closes on Thursday, May 7, 2026. Yelp will issue a press release when its Shareholder Letter has been posted on its investor relations website at www.yelp-ir.com. Following the release of the Shareholder Letter, Yelp will host a webcasted conference call to discuss its first quarter results starting at 2:00 p.m. Pacific Time (5:00 p.m. Eastern Time) on the same day. The live and archived webcasts will be accessible from Yelp's investor relations website at the same web address as above. About Yelp

    4/23/26 4:05:00 PM ET
    $YELP
    Other Consumer Services
    Consumer Discretionary